A recent study from the University of Bristol offers new hope for people with diabetes, who are at a high risk of kidney ...

Diabetes doesn’t just impact blood sugar; it often leads to serious kidney issues, too. In fact, about 40% of people with diabetes develop a condition known as diabetic kidney disease. In the UK, ...

Synedgen, Inc., a biotechnology company targeting human glycobiology to treat gastrointestinal diseases, today announced that it has been awarded a $2.2 million contract from the Joint Warfighter ...

MIIST305, derived from this platform, is a non-systemic therapeutic that modulates innate immune receptor responses and targets the anionic glycocalyx at the gastrointestinal cell surface to ...

MIIST305, derived from this platform, is a non-systemic therapeutic that modulates innate immune receptor responses and targets the anionic glycocalyx at the gastrointestinal cell surface to repair ...

The study was published in the journal Cardiovascular Diabetology wherein the research team was interested in the protective lining of all blood vessels, called the glycocalyx. This lining is known to ...

Pediatric acute respiratory distress syndrome (PARDS), though both common and deadly in critically ill children, lacks targeted therapies. The development of effective pharmacotherapies has been ...

Apart from the catalytic activity, MPO can also recruit and activate neutrophils. This novel article demonstrates a physical interaction between MPO and heparan sulfate, leading to glycocalyx collapse ...